Home

Lüster Reim Selbst achim aigner leipzig university germany Leuchtenden Saugfähig Hingeben

Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Analysis of cellular and molecular antitumor effects upon inhibition of  SATB1 in glioblastoma cells
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection  System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U
SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U

Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich

Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs

Loop | Achim Aigner
Loop | Achim Aigner

Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy

C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig -  ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl
C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig - ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated  siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model

Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma  exerts multiple cellular and molecular antitumor effects | Scientific  Reports
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports

Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in  colon carcinoma
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma

European Technology Platform on Nanomedicine
European Technology Platform on Nanomedicine

Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren  istasyonu ilgisiz yerine getirmek
Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren istasyonu ilgisiz yerine getirmek

MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma  Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma  Industry and MedTech | | Pharma Industry and MedTech Congress
MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma Industry and MedTech | | Pharma Industry and MedTech Congress

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Biocompatibility and Efficacy of Oligomaltose-Grafted Poly(ethylene imine)s  (OM-PEIs) for in Vivo Gene Delivery
Biocompatibility and Efficacy of Oligomaltose-Grafted Poly(ethylene imine)s (OM-PEIs) for in Vivo Gene Delivery

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas -  Academia.edu
PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas - Academia.edu